AMPICILLIN SODIUM (AMPICILLIN SODIUM) — FDA Approval ANDA062772 (HQ SPECLT PHARMA)
AMPICILLIN SODIUM (AMPICILLIN SODIUM) — FDA Approval ANDA062772 (HQ SPECLT PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AMPICILLIN SODIUM; Active ingredients: AMPICILLIN SODIUM; Application number: ANDA062772.
| Brand name | AMPICILLIN SODIUM |
|---|---|
| Active ingredients | AMPICILLIN SODIUM |
| Application number | ANDA062772 |
| Sponsor | HQ SPECLT PHARMA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 8 |
| First approval date | 19930415 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →